Evidence map›Paper›PMID 39738044›Full record

ArticleNature communications2024

The survival of B cells is compromised in kidney disease.

Doureradjou Peroumal, Chetan V Jawale, Wonseok Choi, Hossein Rahimi, Danielle Antos, De-Dong Li, Shuxia Wang, Godhev K Manakkat Vijay, Isha Mehta, Raymond West and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
  4. Review
  5. Observational
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Doureradjou Peroumal *Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-2752-5686
Chetan V Jawale *Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Wonseok ChoiDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Hossein RahimiDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0009-0001-9649-2622
Danielle AntosDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
De-Dong LiDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Shuxia WangDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Godhev K Manakkat VijayDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-3833-3057
Isha MehtaDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0002-6009-0787
Raymond WestDepartment of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.
Muthusamy ThangarajuDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, USA.ORCID 0000-0003-4202-1638
Thomas D NolinDepartment of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-4339-1382
Jishnu DasDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0002-5747-064X
John F AlcornDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0001-5997-7711
Partha S BiswasDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. partha.biswas@stonybrook.edu.ORCID 0000-0002-4570-7443

Funding

RNA binding proteins in end-organ autoimmune pathologyR01AI162616 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2022 to 2026
$3.2M
Mechanisms of neutrophil dysfunction in antifungal immunityR01AI142354 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BISWAS, PARTHA SARATHI, NOLIN, THOMAS DOUGLAS · 2019 to 2023
$2.4M
IL-17-epithelial cells interaction in organ damaging infectionsR21AI181831 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI BISWAS, PARTHA SARATHI · 2024 to 2025
$439k
Mechanisms of renal protection against disseminated candidiasisR21AI159058 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BISWAS, PARTHA SARATHI · 2021 to 2022
$428k
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI142354Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI159058Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI162616Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI181831NIAID NIH HHS R01 AI142354NIAID NIH HHS R21 AI181831
6 · The paper itself

Abstract

Antibody-mediated protection against pathogens is crucial to a healthy life. However, the recent SARS-CoV-2 pandemic has shown that pre-existing comorbid conditions including kidney disease account for compromised humoral immunity to infections. Individuals with kidney disease are not only susceptible to infections but also exhibit poor vaccine-induced antibody response. Using multiple mouse models of kidney disease, we demonstrate that renal dysfunction inhibits germinal center (GC) response against T-dependent antigens. GC B cells exhibit increased apoptosis in kidney disease. Uremic toxin hippuric acid drives loss of mitochondrial membrane potential, leading to increased apoptosis of GC B cells in a G-protein-coupled receptor 109A dependent manner. Finally, GC B cells and antibody titer are diminished in mice with kidney disease following influenza virus infection, a major cause of mortality in individuals with renal disorders. These results provide a mechanistic understanding of how renal dysfunction suppresses humoral immunity in patients with kidney disease.

Indexed as

ApoptosisB-LymphocytesCOVID-19Immunity, HumoralKidney DiseasesAnimalsCell SurvivalDisease Models, AnimalFemaleGerminal CenterHumansMaleMiceMice, Inbred C57BLOrthomyxoviridae InfectionsSARS-CoV-2

Identifiers

PMID39738044
PMCPMC11685736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.